As bladder pain syndrome/interstitial cystitis (BPS/IC) has been demonstrated to proceed through the inflammatory pathways to cause endothelial dysfunction, and endothelial dysfunction is a major factor in the development of ED, it is possible that BPS/IC may be associated with ED. This study set out to investigate the putative association between ED and BPS/IC by using a populationbased data set and case-control design in Taiwan. We obtained the data from Taiwan's National Health Insurance Research Database. Cases included 32 856 ED patients X18-years old and 164 280 matched controls. Conditional logistic regression analyses were performed to compare the odds ratios (OR) and corresponding 95% confidence intervals (CIs) of having been previously diagnosed with BPS/IC in cases and controls. Among the total sample of 197 136 subjects, the prevalence of prior BPS/IC was 0.05%. The prevalence of prior BPS/IC was 0.10% and 0.04% for cases and controls, respectively (Po0.001). Conditional logistic regression analysis revealed that when compared with controls, the OR of prior BPS/IC for cases was 1.75 (95% CI ¼ 1.12-2.71) after adjusting for monthly income, geographic location, hypertension, diabetes, coronary heart disease, hyperlipidemia, renal disease, obesity, depressive disorder, alcohol abuse/alcohol-dependence syndromes and the number of outpatient visits within 1 year before index date. Subjects aged between 18 and 39 were additionally found to have the highest ORs for prior BPS/IC among cases when compared with controls (OR ¼ 10.40; 95% CI ¼ 2.93-36.94). There was an association between BPS/IC and ED. The youngest cases with ED were found to have the strongest magnitudes of association with BPS/IC.
INTRODUCTION
Interstitial cystitis (IC) is a chronic condition characterized by urinary frequency, urgency, pelvic pain relieved with voiding, nocturia and dyspareunia. [1] [2] [3] The International Continence Society now considers 'Bladder pain syndrome' (BPS) to be the preferable term for IC and defines BPS as, 'the complaint of suprapubic pain related to bladder filling, accompanied by other symptoms such as increased daytime and nighttime frequency, in the absence of proven urinary infection or other obvious pathology.' 4 While in the past the prevalence of BPS/IC was generally estimated to be o0.1%, 5 the diagnostic criterion used previously has been found to be overly rigorous. 5, 6 Currently, the prevalence of BPS/IC is known to be 40.1%, ranging between 0.45 7 and 12.6% 8 depending methodological factors. The current understanding of BPS/IC is that of a symptom complex resulting from a variety of separate underlying but potentially interrelated mechanisms, 9 leading clinicians dealing with BPS/IC patients to be cognizant of issues related to other organ symptoms and cognitive, behavioral, emotional and sexual symptoms. 10 One proposed mechanism underlying the pathogensis of BPS/IC involves abnormal bladder permeability, which would allow toxic urinary substances to irritate the underlying bladder tissue, 9 producing epithelial dysfunction, chronic inflammation, and peripheral and central nerve dysfunction. 11 As BPS/IC patients have been suggested to experience sexual manifestations, and the chronic irritation associated with BPS/IC may proceed through endothelial dysfunction to cause ED, it is possible that BPS/IC may be associated with ED. 12 ED is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual intercourse, and is the most common sexual problem among aging men. 13, 14 ED affects up to one-third of men during their lives, and can have a negative impact on intimate relationships, quality of life and self-esteem. 15 Although BPS/IC is more prevalent than previously assumed, and very well may be mechanistically associated with ED, to date, no studies have been conducted investigating the possible association between ED and BPS/IC. Therefore, this study set out to investigate this putative association by using a populationbased data set and case-control design in Taiwan.
MATERIALS AND METHODS Database
We obtained the data from Taiwan's National Health Insurance Research Database (NHIRD). Taiwan began a single-payer National Health Insurance (NHI) Program on 1 March 1995. As of 2007, 22.60 million of Taiwan's 22.96 million population were enrolled in this program (about 98.4% coverage rate). The NHIRD, which contains the registration files and original reimbursement claims data, was derived from the NHI program and maintained by the Taiwan National Health Research Institute. The NHIRD 1 provides researchers with an excellent opportunity to follow-up on all of the medical utilizations of all the enrollees under the NHI program. Many prior studies have demonstrated the high validity of the NHIRD, 16, 17 and hundreds of papers employing the NHIRD have been published in internationally peer-reviewed journals.
This study was exempted from full review by an Institutional Review Board after consulting with the director of the Taipei Medical University Institutional Review Board because the NHIRD consists of de-identified secondary data released to the public for research purposes.
Selection of cases and controls
Cases consisted of 32 856 patients X18 years and who had received their first-time diagnosis of ED (impotence, organic (ICD-9-CM code 607.84)) in their ambulatory care claims (including outpatient departments of hospitals or clinics) during the period between January 2007 and December 2009. No patients who had ever received a diagnosis of psychogenic ED were included in this study. To increase the diagnostic validity of ED, we only included ED patients who had received X2 ED diagnoses during the period between 2007 and 2009, with at least one of the diagnoses being made by a urologist. Furthermore, there is also no incentive to be diagnosed as pharmaceutical treatment for ED is not covered under the Taiwan NHI program. Therefore, we believe that the ED diagnoses had high validity in Taiwan. For cases, we assigned the date of their first ED diagnosis as the index date.
Controls for this study were likewise retrieved from the NHIRD. We first selected all the subjects X18 years of age and who had never received a diagnosis of ED since the beginning of the NHI program in 1995. Thereafter, we randomly selected 164 280 controls (five controls per case) matched with cases in terms of age in intervals of 10 years (o30, 30-39, 40-49, 50-59, 60-69 and X70), urbanization level and index year. In Taiwan, all 359 cities/towns in Taiwan were stratified into five groups ranked by urbanization level, with 1 referring to the 'most urbanized' and 5 referring to the 'least urbanized'. We matched the distribution of urbanization level between cases and controls to assure that cases and controls were reasonably similar in terms of unmeasured neighborhood socioeconomic characteristics. We assigned the date of their first use of medical services occurring during the index year as the index date for controls.
Exposure assessment
We identified BPS/IC cases based on ICD-9-CM code 595.1 (chronic IC). This study only included BPS/IC cases if the diagnosis of BPS/IC was received within the 5 years preceding their index date. In addition, we only included patients who had received Cystistat treatment, which is covered under the NHI program. Under the NHI program, prescriptions for Cystistat are tightly regulated. In addition to reviewing the patient's medical history, performing a complete pelvic examination, and getting a positive result from a potassium sensitivity test, according to the regulations of the NHI, in order to prescribe Cystistat, an attending physician is absolutely required to perform a hydrodistention test coupled with cystoscopy, demonstrating at least one severe abnormality according to the diagnostic criteria proposed by the European Society for the Study of IC/PBS. 18 Although this test is invasive compared with the trend drifting toward less invasive diagnostic criteria used abroad, it is considered to be the gold standard for the diagnosis of IC/BPS. 19 Therefore, it is very unlikely that anyone without a clear diagnosis of BPS/IC would be eligible for this treatment, and equally unlikely that misdiagnosed cases were included in our study.
Statistical analysis
We used the SAS system (SAS System for Windows, Version 8.2, SAS institute, Cary, NC, USA) for analysis in this study. The w 2 -tests were performed to compare the differences in the distributions of medical comorbidities (hypertension, diabetes, coronary heart disease (CHD), hyperlipidemia, renal disease, obesity, depressive disorder and alcohol abuse/alcohol-dependence syndrome) between cases and controls. These medical co-morbidities were selected because they were reported to be associated with ED. In addition, we performed conditional logistic regressions (conditioned on age group, urbanization level and index year) to compare the odds ratios (ORs) and corresponding 95% confidence intervals (CIs) of having previously receiving a diagnosis of BPS/IC in cases and controls after taking these medical co-morbidities and the number of outpatient visits within 1 year before index date into consideration. We used the conventional Pp0.05 as statistically significant in this study.
RESULTS
Of the 32 856 cases and 164 280 controls, the mean age was 49.2 years ( ± 12.5). Table 1 shows the distribution of demographic characteristics and co-morbidities for cases and controls. After matching for age group and urbanization level, cases had a higher prevalence of co-morbidities of hyperlipidemia (30.8% vs 17.5%, Po0.001), diabetes (21.7% vs 12.7%, Po0.001), hypertension (34.5% vs 26.2%, Po0.001), CHD (15.7% vs 10.3%, Po0.001), renal disease (4.1% vs 3.5%, Po0.001), obesity (0.7% vs 0.4%, Po0.001), depressive disorder (3.8% vs 1.8%, Po0.001) and alcohol abuse/ alcohol-dependence syndrome (0.8% vs 0.6%, Po0.001) than controls. In addition, the mean number of outpatient visits within 1 year before index date was 25.6 and 17.5 for cases and controls, respectively (Po0.001).
The prevalence and OR of prior BPS/IC for cases and controls was presented in Table 2 . Among the total sample of 197 136 subjects, the prevalence of prior BPS/IC was 0.05%. The prevalence of prior BPS/IC was 0.10% and 0.04% for cases and controls, respectively (Po0.001). Conditional logistic regression analysis (conditioned on age group, urbanization level and index year) also shows that compared with controls, the OR of prior BPS/IC for cases was 2.19 (95% CI ¼ 1.45-3.32). We further found that ED was significantly associated with prior BPS/IC (OR ¼ 1.75; 95% CI ¼ 1.12-2.71) after adjusting for monthly income, geographic location, hypertension, diabetes, CHD, hyperlipidemia, renal disease, obesity, depressive disorder, alcohol abuse/alcoholdependence syndromes and the number of outpatient visits within 1 year before index date. 
DISCUSSION
To the best of our knowledge, this is the first large-scale population-based study conducted investigating the relationship between ED and BPS/IC. Our results demonstrated that men suffering from ED had a higher risk than the general population for having been previously diagnosed with ICP/BPS after controlling for patient's monthly income, geographic region, hyperlipidemia, diabetes, hypertension, CHD, obesity, renal disease, depressive disorder, alcohol abuse/alcohol-dependence syndrome and the number of outpatient visits within 1 year before index date (OR ¼ 1.75). After stratifying by age, we found the youngest age group to demonstrate the largest magnitude of association (OR ¼ 10.40). This association fell precipitously for those aged 40-59 years (OR ¼ 1.44), and was insignificant in those aged X60 years.
The prevalence of ED increases with age for more reasons than endothelial dysfunction alone, 12 and it is possible that the weaker association detected in men aged 40-59 years, and our inability to detect an association in men aged 460 years, may be due to a greater proportion of men in these age groups suffering from ED arising from pathologies unrelated to BPS/IC that we could not control for in our models. One such example may include agerelated decreases in testosterone levels. Another possible factor contributing to the weaker associations in older men may involve increased peripheral vascular resistance, resulting from the narrowing of the lumen on account of accumulations on vessel walls. 20 Such increased resistance has been shown to result in structural changes to the penile vasculature, including both arterial and erectile tissues. 21 As we did not have information on the hormone levels or vascular resistance of the ED cases in this study, it is possible that the inclusion of a greater proportion of ED cases not stemming from BPS/IC-associated inflammation diluted the association in this older age groups.
It is also likely that the weaker associations detected among the older age groups can be explained through a surveillance bias. If the younger group were more sexually active than their more mature counterparts, they would be more likely to realize that they were suffering from ED purely on account of having more opportunities to experience and realize their dysfunction. This possibility is supported by a study conducted on 412 men and 204 women 465 years in Taiwan, among whom only 35.7% were sexually active, and only with a frequency of 21.4 (s.d. ¼ 16.9) times per annum. 22 For the younger age groups, the mechanisms underlying the associations detected in this study between BPS/IC and ED are likely to involve chronic inflammation-induced endothelial dysfunction.
Although the etiology and pathogensis of BPS/IC are yet to be elucidated, there is general consensus that a defect in the urothelial lining has a major causative role. [23] [24] [25] [26] Several studies indicate that the defective bladder glycosaminoglycan layer arises from proteoglycan dysfunction and results in an enhanced permeability of the bladder wall. 9, 27, 28 On account of this defect, the underlying urothelium is exposed to noxious stimuli that triggers a cascade of events setting up a cycle of neuroupregulation and inflammation. 24, 29, 30 This is supported by a number of studies that have demonstrated BPS/IC patients to abnormally secrete APF, nerve growth factor, inflammatory cytokines, adenosine triphosphate and multiple other signaling molecules, 9 with these molecules also being shown to persist even once removed from the body and grown in cellular culture. [31] [32] [33] BPS/IC patients have further been demonstrated to have an increased density of nerve fibers, which may be related to mast cells, which when activated release histamine and other inflammatory molecules. 33 Therefore, the irritation related to BPS/IC can cause tissue injury and result in the activation of both Abbreviations: CI, confidence interval; OR, odds ratio. OR was calculated by conditional logistic regression that was conditioned on age group. ***indicates Po0.001.
a Adjustments are made for patient's monthly income, geographic region, hyperlipidemia, diabetes, hypertension, coronary heart disease, obesity, renal disease, depressive disorder, alcohol abuse/alcohol-dependence syndrome and the number of outpatient visits within 1 year before index date. Adjustments are made for patient's monthly income, geographic region, hyperlipidemia, diabetes, hypertension, coronary heart disease, obesity, depressive disorder, renal disease, alcohol abuse/alcohol-dependence syndrome and the number of outpatient visits within 1 year before index date.
inflammatory cells and oxidant-generating enzymes, 34 and cause endothelial dysfunction, thus leading to ED.
ED's reputation as a marker for endothelial dysfunction is supported by both the plethora of mechanisms that have been proposed to underpin ED's association with other diseases, [35] [36] [37] as well as by clinical studies conducted on vasculogenic ED patients, demonstrating that they have markedly impaired endothelial and smooth muscle function. 38 Although the endothelial cells responsible for penile erection are not co-localized with the source of inflammation in the bladder lining of patients with BPS/IC, they could suffer from systemic oxidative stress as the endothelium is in direct contact with circulating blood. On account of the proximity of the bladder to the penile endothelium and the chronic nature of BPS/IC, even comparatively low concentrations of inflammatory cytokines and oxidative stress may contribute strongly to the development of ED. This type of pathomechanism has been verified in a previous study, which demonstrated that postprandial hypertriglyceridemia and hyperglycemia, which also exhibit systemic oxidative stress, have an independent and cumulative effect on endothelial function. 39 As it has been demonstrated that chronic pain can cause sexual dysfunction, [40] [41] [42] another possible explanation for the association seen in this study may involve the chronic pain associated with IC/BPS. [1] [2] [3] Current research suggests that the pain attributed to chronic pain disorders differs mechanistically from acute pain, with the most predominantly contributing factors stemming from the central nervous system. What were once understood to be a diverse range of disorders, including migraine, irritable bowel syndrome and BPS/IC, are more recently coming to be recognized as different manifestations arising from a common set of central nervous system processes, with neurotransmitters analogically acting as the 'volume control' of the pain processes involved. 43 Neurotransmitter regulation is one critical juncture in the translation of long-term steroid effects into rapid behavioral events, 44 with dopamine long being known to enhance sexual motivation and copulatory behavior. 45 It is released before and during copulation in several key integrative sites, and has also long been known to facilitate masculine sexual function clinically. 44 Therefore, as the neurotransmitter pathways, such as those of dopamine, have been suggested to be associated with both ED and migraine, it is possible that the dysregulation of the neurotransmitter pathways is one mechanism underlying the associations detected in this study. 43, 44 The primary strength of our study lies in its longitudinal database and large sample population, which mitigates the effect of the selection biases inherent in studies utilizing data taken from voluntary registries and hospital-referred study patients. Another two-edged aspect to using this database is that over 98% of Taiwan's residents are of Han Chinese ethnicity. While the homogenous population may exempt our study from potential confounding by race, it also limits its generalizability to other ethnic groups.
There are several limitations to our study. The first is the use of ICD-9 coding in the administrative database to diagnose ED. These diagnoses may be less accurate than those derived from studies acquiring data through standardized prospective methodologies. We did, however, ensure that none of the ED cases in this study had ever been diagnosed with premature ejaculation to mitigate the possibility of miscoding. Furthermore, while we only included ED patients who had received X2 ED diagnoses during the period between 2007 and 2009, 92% of the patients in Taiwan that received one ED diagnosis during that time period also went on to receive a second.
Second, individual information such as smoking, body mass index, alcohol consumption and marital/partner status, all of which may contribute to ED, was not available through the administrative data set. The inability to adjust for these potential confounding factors may compromise the findings of the present study.
Third, as discussing sexuality is relatively culturally taboo in Taiwan, many patients with ED may not wish to see a specialist despite their disability. This may account for the seemingly low incidence of ED when compared with studies from western countries, and lead to the possibility that some of the controls in this study were also suffering from ED. However, if such a bias exists in the data, the results of our analysis would be biased toward the null. Furthermore, this also goes to increase the validity of the ED diagnoses utilized in this study. Not only may a Taiwanese be reluctant to admit suffering from a shameful condition but also there is no incentive to be diagnosed as pharmaceutical treatment for ED is not covered under the NHI program.
CONCLUSION
This investigation succeeded in identifying an association between BPS/IC and ED. After stratifying by age, the youngest cases with ED were found to have the strongest magnitudes of association with BPS/IC. We suggest that urologists be alert to the association between BPS/IC and ED, and be more attentive to sexual complaints from patients with BPS/IC in order to propose a therapy.
